Robert Baldassano
Overview
Explore the profile of Robert Baldassano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
6318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitchel E, Huang J, Zemel B, Baldassano R, Albenberg L, Denburg M
J Pediatr Gastroenterol Nutr
. 2024 Jan;
78(1):85-94.
PMID: 38291691
Background: There is increasing recognition that children with Crohn's Disease (CD) can develop obesity. Methods: Using the RISK Study, an inception cohort of pediatric CD participants, and Bone Mineral Density...
2.
Harris R, Bush A, Eagar T, Qian J, Greenwood M, Opekun A, et al.
J Pediatr Gastroenterol Nutr
. 2023 Jun;
77(3):354-357.
PMID: 37347142
Non-caseating granulomas may indicate a more aggressive phenotype of Crohn disease (CD). Genetic associations of granulomatous CD (GCD) may help elucidate disease pathogenesis. Whole-exome sequencing was performed on peripheral blood-derived...
3.
Zhang N, Liu C, Steiner S, Colletti R, Baldassano R, Chen S, et al.
J Comp Eff Res
. 2023 Feb;
12(4):e220136.
PMID: 36799351
To evaluate the performance of the multiple imputation (MI) method for estimating clinical effectiveness in pediatric Crohn's disease in the ImproveCareNow registry; to address the analytical challenge of missing data....
4.
Constant B, Baldassano R, Kirsch J, Mitchel E, Stein R, Albenberg L
J Pediatr Gastroenterol Nutr
. 2022 Sep;
75(6):724-730.
PMID: 36122389
Objectives: Colectomy rates following acute severe ulcerative colitis have plateaued around 20% despite intravenous corticosteroid and intensified anti-tumor necrosis factor (TNF) biologic dosing. Recent studies have shown tofacitinib to provide...
5.
Moore H, Dubes L, Fusillo S, Baldassano R, Stein R
J Pediatr Gastroenterol Nutr
. 2021 Jun;
73(3):e57-e62.
PMID: 34091545
Objectives: Tofacitinib, a selective Janus kinase inhibitor, effectively induces and maintains remission in adults with inflammatory bowel disease (IBD), but data are limited in children. This study aimed to evaluate...
6.
Hyams J, Brimacombe M, Haberman Y, Walters T, Gibson G, Mo A, et al.
Inflamm Bowel Dis
. 2021 Apr;
28(2):151-160.
PMID: 33904583
Background: Develop a clinical and biological predictive model for colectomy risk in children newly diagnosed with ulcerative colitis (UC). Methods: This was a multicenter inception cohort study of children (ages...
7.
Marcovitch L, Focht G, Horesh A, Shosberger A, Hyams J, Bousvaros A, et al.
J Pediatr Gastroenterol Nutr
. 2021 Mar;
73(2):e35-e38.
PMID: 33720091
As part of the development of the TUMMY-UC, a patient-reported outcome (PRO) measure for pediatric ulcerative colitis (UC), we aimed to explore agreement on UC symptoms between children and their...
8.
Ta A, Ollberding N, Karns R, Haberman Y, Alazraki A, Hercules D, et al.
Inflamm Bowel Dis
. 2021 Jan;
27(11):1707-1718.
PMID: 33452801
Background: Transmural healing (TH) is associated with better long-term outcomes in Crohn disease (CD), whereas pretreatment ileal gene signatures encoding myeloid inflammatory responses and extracellular matrix production are associated with...
9.
Moore H, Wechsler J, Frost C, Whiteside E, Baldassano R, Markowitz J, et al.
J Pediatr Gastroenterol Nutr
. 2020 Nov;
72(3):398-403.
PMID: 33230079
Background And Aims: The incidence and prevalence of eosinophilic esophagitis (EoE) and inflammatory bowel disease (IBD) are rising with similar patterns. Co-occurrence of both diseases in the same patient has...
10.
Gu C, Zhao C, Hofstaedter C, Tebas P, Glaser L, Baldassano R, et al.
PLoS One
. 2020 Nov;
15(11):e0236533.
PMID: 33166284
Mycobacterium chelonae is a rapidly growing nontuberculous mycobacterium that is a common cause of nosocomial infections. Here we describe investigation of a possible nosocomial transmission of M. chelonae at the...